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Immobilization and purification of enzymes are usual requirements for their industrial 27 
use. Both purification and immobilization have a common factor: they use a solid 28 
activated support. Using a support for enzyme purification means having mild 29 
conditions for enzyme release and a selective enzyme-support interaction is interesting. 30 
Using a support for immobilization, enzyme desorption is a problem. The improvement 31 
of enzyme features via immobilization is a usual objective (e.g., stability, selectivity) 32 
Thus, a support designed for enzyme purification and a support designed for enzyme 33 
immobilization may differ significantly. In this review, we will try to focus the attention 34 
on the requirements of a support surface to produce the desired objectives. The ideal 35 
physical properties of the matrix, the properties of the introduced reactive groups, the 36 
best surface activation degree to reach the desired objective, and the properties of the 37 
reactive groups will be discussed. 38 
 39 
Key words: Enzyme purification, enzyme immobilization, enzyme stabilization, 40 
superficial density of reactive groups, multipoint attachment, one point attachment. 41 
  42 
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1- Introduction 43 
 The chemical industry of the 21st century intends to produce very complex 44 
products in a sustainable way to give solutions to the public demands concerning 45 
pharmaceutical, food and fine chemistry companies.[1] It is in this sense where enzymes 46 
have found their natural niche as industrial biocatalysts. They are extremely selective 47 
and specific, able to catalyze reactions at low temperature and pressure, even in aqueous 48 
media.[2] However, these natural biocatalysts have been designed by nature during 49 
evolution to fulfill some physiological requirements, and some of their properties are 50 
quite far from the industrial requirements.[3] Thus, enzymes are water soluble, prone to 51 
suffer inhibitions, and with low stability. Their exceptional activity, specificity and 52 
selectivity are found within physiological substrates and reactions. Then again, in 53 
industry the researcher intends to use the enzyme with a different substrate and, in many 54 
instances, in a very different reaction.[4] Moreover, enzymes are accompanied by many 55 
other enzymes in microorganisms, sometimes with activities against the same substrate. 56 
A particular enzyme may be specific and selective, but if the contaminant enzymes have 57 
opposite (or just different) properties, this may reduce the apparent performance of the 58 
prepared biocatalyst.[5] Even in the best scenario, the contaminant proteins will reduce 59 
the volumetric activity of our biocatalyst.[6]  60 
 Fortunately, researchers have many tools to improve enzyme performance that 61 
have experienced a very rapid development in the last years, for example, microbiology 62 
and genetics have promoted a revolution in biocatalysis.[7] Enzyme performance has 63 
been improved via site-directed mutagenesis.[8] Moreover, it is now possible to mimic 64 
the natural evolution targeting the desired enzyme property via directed evolution.[3c] 65 
Metagenomic tools permit to produce enzymes whose origin may be fully unknown,[9] 66 
e.g., extremophiles is nowadays a source of thermostable enzymes with novel properties 67 
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just by using DNA from thermophilic environments.[9a] However, these improvements 68 
of enzyme properties have not avoided the fact that enzymes still need to be purified 69 
and their recovery after the reaction may be complex. Activated supports are a key to 70 
solve both problems, easing the industrial implementation of enzymes; enzyme 71 
purification (to eliminate all enzymes able to catalyze any unwanted modification of the 72 
substrates or products of the reaction)[10] and immobilization (to simplify the enzyme 73 
reuse) [11] may require the use of activated supports. The rapid development on materials 74 
science has permitted to increase the availability of new activated supports and to better 75 
understand the behavior of others: nanomaterials,[12] hybrid materials,[13] tailor made 76 
silicates,[14], etc. 77 
Immobilization, being almost compulsory, has been used by many researchers as 78 
a tool to improve various enzyme features, such as activity, selectivity, specificity, 79 
resistance to inhibitors, etc.[15] Rocha-Martin, J., Acosta, A., Berenguer, J., Guisan, 80 
J.M., Lopez-Gallego, F.Selective oxidation of glycerol to 1,3-dihydroxyacetone by 81 
covalently immobilized glycerol dehydrogenases with higher stability and lower 82 
product inhibition (2014) Bioresource Technology, 170, pp. 445-453 In some cases, 83 
some immobilization protocols have permitted the one-step immobilization and 84 
purification by a careful control of the support and/or immobilization conditions (Figure 85 
1).[16] Nowadays, an immobilization protocol that does not permit the solution to some 86 
other enzyme limitations is not considered a good immobilization protocol. 87 
Both for immobilization and purification, an adequate selection of the support 88 
and of the protocol are critical. There are many parameters that define a support: 89 
internal geometry (e.g., flat surfaces or thin fibers), specific surface area, superficial 90 
activation degree, mechanical resistance, pore diameter, etc.[11b,17] In some instances, 91 
some positive properties of a support for enzyme immobilization may be also positive 92 
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for enzyme purification, but in general they have a critical difference in the objective 93 
that may cause the optimal properties for each support to be different. While for enzyme 94 
purification, having an easy release of the enzyme from the support is mandatory to 95 
avoid enzyme inactivation, enzyme immobilization requires a strong enzyme-support 96 
attachment. Thus, the undesired release of the enzyme during operation needs to be 97 
avoided for enzyme immobilization while a too strong enzyme-support interaction may 98 
be unsuitable for enzyme purification (Figure 2).[15]    99 
One critical key parameter when using a support for purification or 100 
immobilization is the identification of the first cause for enzyme interaction with it. In 101 
some instances, the interaction of one group in the support with the enzyme is enough to 102 
fix the enzyme to the support, while in many other cases, it is necessary to establish the 103 
interaction of several groups of the support with several groups of the enzyme.[18] After 104 
immobilization, other phenomena (desired or undesired) may occur, but the researcher 105 
must detect these phenomena and develop tools to control them. That is, the first 106 
immobilization may be via a one point or a multi-interaction, and after this 107 
immobilization, the support may continue increasing the number (or even the quality) of 108 
the interactions,[19] involving new groups as it is the case when using heterofunctional 109 
supports (Figure 3).[20]  110 
Next, we will discuss how the properties of the support and the reactive groups 111 
placed on its surface may determine its suitability for being used for enzyme 112 
immobilization or purification, mainly at industrial level. In most cases, the same 113 
parameter may have some positive and some negative effects, compromise solutions use 114 
to be required to get optimal results, and each of this may depend on the particular 115 




2- Mechanical properties of the support for immobilization or purification 118 
In this case, immobilization and purification have similar demands. The 119 
selection of the mechanical properties will depend on the final configuration of the 120 
reactor more than in the application for purification or immobilization .[6] If the reactor 121 
is a fixed bed reactor, it should possess very high rigidity to withstand high pressures 122 
without pressure problems.[6] Silica-based materials,[14b,21] carbon materials,[22] 123 
inorganic oxides,[23] porous glass and other mineral materials as copper phosphate or 124 
cobalt phosphate (by mineralizing cobalt-phosphate in the presence of His-tagged 125 
enzymes) Selective biomineralization of Co3(PO4)2-sponges triggered by His-tagged 126 
proteins: efficient heterogeneous biocatalysts for redox processes Fernando López-127 
Gallego and Luis Yate  Chem. Commun., 2015, DOI: 10.1039/C5CC00318K, 128 
montmorillonite and bentonite[24] may be a very good selection for a column. The 129 
situation is different if a stirred tank reactor is used, the mineral materials will be broken 130 
in these systems, while other flexible materials may be more adequate, such as agarose 131 
beads (the bad mechanical resistance to magnetic stirring has led to consider these 132 
material inadequate for stirred tank configurations, but using mechanical stirring the 133 
resistance is very high),[25] cellulose beads,[26] Lentikats (polyvinyl alcohol polymers 134 
shaped like a lens),[27] etc. Agarose beads are usually used in enzyme purification using 135 
a column configuration, but this requires using a very low flow rate, because the low 136 
rigidity produces pressure problems at high column height and rapid flows.[25a,25c] Some 137 
new more rigid agarose beads permit to stand higher pressures. 138 
Some commercial materials, mostly from organic polymers, are more or less 139 
adequate for both reactor configurations. Examples are epoxy acrylic beads (e.g., 140 
Sepabeads, Eupergit),[28] styrene,[29] styrene-divinylbenzene beads,[30] Lewatit,[31] etc. 141 
Other reactor configurations, like fluidized-bed,[32] vortex reactors,[33] etc. may be less 142 
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demanding for the support mechanical resistance. Although agarose beads are 143 
traditionally used in purification due to their good inertness properties, over 100 papers 144 
and patents have been published on the use of organic polymers in enzyme purification. 145 
The purification in a stirred tank is only possible if the support is able to produce 146 
a selective adsorption of the target enzyme, as the selective desorption using a gradient 147 
is far less efficient using a stirred system than using a column.[34] In biocatalysis, the 148 
selection of one reactor configuration may depend on many different factors (enzyme 149 
kinetics, control of pH, supply of oxygen, and other features of the reaction may make a 150 
stirred tank or a bed reactor more or less suitable), sometimes even on the available 151 
facilities on a specific factory or the volume of substrate to be processed.[35] That way, 152 
the properties of the support need to be chosen considering the final reactor to be 153 
utilized, but a handful of supports with different mechanical properties are available at 154 
similar prices. 155 
 156 
3. The role of the particle size in a support for enzyme immobilization or 157 
purification. 158 
 The particle size plays a very important role in the handling of the particles, both 159 
for purification and biocatalysts preparation. Large particles may be retained more 160 
easily than small ones, but they may have some problems that we will detail below. Too 161 
small particles may become almost impossible to handle under industrial conditions.  162 
Production of large particles may be a problem in some instances, and the use of the 163 
support may generate fine particles that can produce problems after several cycles, thus 164 
this may be to a certain degree related to the mechanical resistance of the support. Thus, 165 
a compromise solution needs to be reached.[6] 166 
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In a column (for enzyme purification or biocatalysis), very large particles may 167 
favor the occurrence of preferential ways in the column decreasing the resolution of the 168 
column or the observed catalytic activity. Moreover, some diffusional problems of the 169 
enzyme molecules in very long pores may decrease the rate of enzyme adsorption, 170 
slowing down the full coating of the support surface by the enzyme (Figure 4).[36] Also, 171 
as these particles may have an ionic nature and thus they may behave as a “solid 172 
buffer”, the change in the pH in enzyme purification using ionic exchange may not be as 173 
immediate as desired, producing also a decrease in the final resolution of the column.  174 
If the purification is performed in batch via selective adsorption, just a delay in 175 
the adsorption rate may be found using a large particle, in many instances the 176 
advantages of large particle handling may make up for this delay on the enzyme 177 
adsorption. 178 
In biocatalysis (under any reactor configuration), large particles may give rise to 179 
larger diffusional problems. The diffusional problems are not always negative for the 180 
enzyme performance, but in general they may produce a decrease in enzyme activity.[37] 181 
For example, if the substrate diffusion rate is slower than the substrate consumption 182 
rate, it is possible that the enzyme molecules located in the core of the support will not 183 
receive any substrate, thus being apparently fully inactive and decreasing the observed 184 
activity of the biocatalysts (Figure 5).[37b,37e] Other phenomena favored by the size of the 185 
particle are the promotion of pH gradients if the product has an ionizable group (e.g., in 186 
hydrolysis of an ester releasing a carboxylic acid).[38] This produces a decrease in the 187 
pH along the pore of the biocatalysts particle, and makes it impossible to use the 188 
enzyme under optimal pH conditions (because each enzyme molecule may be at a 189 
different pH value depending on their position on the pore) (Figure 6). This is not 190 
always negative. In some instances, this may be used to improve enzyme stability, for 191 
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example if the reaction is performed at alkaline pH value (e.g., due to product solubility 192 
or stability) and the enzyme stability/activity is higher at acidic pH value. An example 193 
of this is the hydrolysis of penicillin G catalyzed by penicillin G acylase.[39] The 194 
reaction is performed at pH 8 due to the adequate enzyme activity and substrate/product 195 
stability under these conditions, but the enzyme is more stable at acidic pH values. If a 196 
pH gradient is permitted, the initial activity decreased by almost a 50%, but the time to 197 
get full hydrolysis only increased by 20% and the stability of the enzyme increased 198 
several times, making it interesting to explore this pH gradient as a way to improve 199 
enzyme productivity. 200 
Other problem related to the promotion of gradients of substrates, products, pH, 201 
etc. inside the pores of the particle is the apparent changes in enantio-specificity of an 202 
enzyme used in a kinetic resolution of racemates.[40]  203 
The existence of substrate limitations for the biocatalyst in the inner part of the 204 
particle may make that these enzyme molecules may only act versus the “worst” 205 
substrate because the “good” one has been fully modified by the enzymes nearer to the 206 
particle surface, worsening the final results. On the other hand, the change on the 207 
internal pH, by pH gradients, may alter the behavior of the enzyme, improving or 208 
decreasing the final enantiomeric excess of the product; this fact needs to be considered 209 
in the studies.[15a] In these cases, the particle size is very important to determine the 210 
relevance of the diffusion limitations. Boniello, C., Mayr, T., Bolivar, J.M., Nidetzky, 211 
B. Dual-lifetime referencing (DLR): A powerful method for on-line measurement of 212 
internal pH in carrier-bound immobilized biocatalysts (2012) BMC Biotechnology, 12, 213 
art. no. 11. 214 
If the particle is coated with some ionic group or an ionic polymer (e.g., 215 
polyethylenimine), this particle will behave as a “solid buffer”.[15a]. This may decrease 216 
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the existence of pH gradient produced by the catalytic enzyme activity. Moreover, this 217 
may permit to keep the enzyme inside the particle protected from external changes in 218 
the pH value caused by the addition of titrating reagents (e.g., used in many reactions 219 
where a carboxylic acid is released) (Figure 7), this protection will increase when the 220 
size the particle does. 221 
Thus, the size of the particle, and if this particle is loaded to the maximum or an 222 
intermediate enzyme load is recommended, depend on many points. For example, the 223 
reactor configuration, if the enzyme activity versus the target substrate is very high or it 224 
is very low, the real effect of the changes in medium on enzyme properties, the kind of 225 
reaction that we are performing. In some cases, only a decrease in activity is observed 226 
and this slower reaction time may be assumed by the easing of the biocatalyst handling 227 
(that also may save time). However, in a kinetic resolution a decrease in the final 228 
product quality cannot be assumed in any case.[40] Obviously, the handling of the 229 
particle will be kept in mind during all the optimization process of the biocatalyst. 230 
 231 
4- Relevance of the support pores size and specific area for enzyme immobilization 232 
or purification  233 
 Pore size and specific surface area of a porous particulate support are related 234 
parameters: in general, the larger the pores, the smaller the specific area.  235 
The specific area, if the enzyme can penetrate the pores of the particle, 236 
determines the loading capacity of the support.[11b,17a,41] At first glance, the best support 237 
is that having the highest loading capacity, because that way it is possible to 238 
purify/immobilize a larger amount of enzyme using a lower volume of support. It is 239 
possible to decrease the loading of the support if any kind of problem arises due to a 240 
very high enzyme activity (see section 3 of this review), but we cannot load more 241 
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enzyme than that determined by the specific area of the matrix if the specific activity of 242 
the enzyme is low and diffusional problems are not expected. Thus, in general a large 243 
specific area is recommended from an economical point of view. 244 
The pore diameter determines the size of the protein that can be immobilized on 245 
that support.[42] It should be considered that the pore must permit the entry of new 246 
enzyme molecules once there are confronted enzyme molecules already immobilized to 247 
avoid the closing of the pore. Thus, the diameter of the pore needs to be 4-5 folds larger 248 
than the enzyme larger diameter if we intend to ensure the full coating of the support 249 
surface with the enzyme in a reasonable time.[43] It should be considered that the 250 
required pore diameter will be determined by the size of the larger protein able to 251 
become adsorbed on it, both in purification or immobilization, and the use of pores 252 
based just on the size of the target protein may generate problems to have a full loading 253 
of the support (Figure 8).[6] Even if a selective adsorption is intended, the 254 
immobilization of traces of very large proteins (that on the other hand are those that can 255 
more easily become immobilized due to their higher possibilities of establishing multi-256 
interaction with the support surface) may produce the closing of the pores, drastically 257 
reducing the loading capacity of the supports.[6] 258 
Some other factors may be modulated by the pore diameter size. For example, 259 
this parameter may affect the diffusion of the substrates. The use of supports bearing 260 
very small diameter pores may increase the diffusional limitations and this may have 261 
special relevance if the substrates are very large macromolecules, such as proteins or 262 
other polymers (Figure 9).[43a] Moreover, very large pores produce a lower mechanical 263 
resistance of the support particle. 264 
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Thus, it is again necessary to reach a compromise solution that may permit 265 
sufficiently good results in the different parameters, considering loading capacity and 266 
size of protein/substrates. 267 
 268 
5- Influence of the internal morphology of the support on the intensity of the 269 
protein/support interactions 270 
 Previous points affected mainly the biocatalysts performance at “macroscopic” 271 
level. From this point, the interaction between enzyme molecules and the supports will 272 
be analyzed at “molecular level”. 273 
After the enzyme penetrates the particle, the internal morphology of the support 274 
will determine the possibilities of getting a very intense (ideally involving all likely 275 
groups of the protein)[44] or a very limited enzyme molecule-support interaction (ideally 276 
just one point).[45]  277 
If the support is composed of macromolecular fibers, having a diameter size 278 
smaller than that of the enzyme, it is hard to get an intense enzyme-support multi-279 
interaction[44b] (e.g., Toyopearl, Sephacel). If the support has large internal surfaces, 280 
enough to resemble that the enzyme molecule is interacting with a flat surface, it is 281 
possible to get an intense multi-interaction involving over 30% of the enzyme surface 282 
(e.g., agarose beads, porous glass or silicates, Sepabeads).[6] Moreover, these supports 283 
may have a higher mechanical resistance. Some supports are in between (e.g., 284 
Eupergit),[28c,46] those permit only a moderate enzyme-support multi-interaction.[28a,47]  285 
 The enzyme support-multi-interaction has different relevance for enzyme 286 
purification or immobilization. 287 
 Most of the chromatographic matrices for protein purification base their enzyme 288 
adsorption capacity on the establishment of many weak enzyme-support interactions, 289 
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that is, the enzyme is only incorporated to the support if many enzyme-support 290 
interactions are achieved.[48] Ionic exchangers, hydrophobic, immobilized metal chelates 291 
(IMAC) (for native proteins) matrices are examples of this kind of supports, all of them 292 
widely used in protein purification.[49] These supports usually are intended to adsorb 293 
most of the proteins on the crude extract and the purification is obtained via selective 294 
desorption (Figure 10). Therefore, a support that did not permit an intense enzyme-295 
support multi-interaction does not seem very adequate; e.g., many proteins can be 296 
unable to become adsorbed on thin fibers. However, if enzyme adsorption is based on a 297 
single and strong point interaction with the support (e.g., affinity chromatography, 298 
IMAC for poly His tagged proteins),[50] the possibilities of a multi-interaction far for 299 
being an advantage becomes a problem.[45,51] It should be considered that many of the 300 
ligands used in affinity chromatography and the IMAC matrices are not physically inert 301 
(they are ionic, hydrophobic, able to give hydrogen bridges, etc.), but may interact with 302 
different moieties of the enzyme molecules.[52] If a multi-interaction is favored, 303 
undesired protein molecules may become adsorbed on the support via this alternative 304 
mechanism, reducing the purification factor achieved (Figure 11). Moreover, even if the 305 
adsorption of the protein remains selective, the affinity adsorbed protein molecules may 306 
unspecifically interact with these groups, leading to enzyme inactivation or to 307 
difficulties to get the enzyme desorption. In the case of large proteins, able to establish a 308 
very intense enzyme-support multi-interaction, this may produce the impossibility of 309 
getting enzyme desorption in an active form.[53] The purification via selective adsorption 310 
of the target protein will save support surface and may permit the purification using a 311 
stirred tank configuration and not columns, because it is no longer necessary to have a 312 
sophisticated gradient to have the selective desorption of the enzyme from the support. 313 
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 In protein immobilization, the control of the number of enzyme-support 314 
interactions is even more relevant.  In the case of a physical adsorption, the number of 315 
enzyme-support interactions determines the range of conditions where the biocatalysts 316 
may be used: a higher number of interactions will permit a stronger adsorption, and 317 
thus, a biocatalyst that may be used in a broader range of conditions and for more 318 
enzymes.[6] In some instances, the support surfaces are even coated with ionic polymers 319 
to permit a tridimensional enzyme-support interaction, and that way, a very strong 320 
enzyme adsorption (Figure 12).[54]  321 
 In the case of covalent attachment, the enzyme multipoint covalent 322 
immobilization has been described as a powerful tool to improve enzyme rigidity, and 323 
that way, enzyme stability.[15b,17a,55] This is based on the fact that the relative positions 324 
of all groups involved in the immobilization cannot alter their relative positions under 325 
any circumstance (no more than the size of the spacer arm).[44,56] Thus, for this goal, a 326 
support permitting an intense multipoint interaction with the enzyme is preferred: this 327 
stabilization strategy may be only obtained using supports bearing large flat 328 
surfaces.[44b] However, if the support is not fully inert after immobilization, the 329 
possibility of suffering an intense uncontrolled interaction with the support may have 330 
negative effects on enzyme stability (Figure 3). For example, the blocking of the 331 
support with hydrophilic compounds is critical using Sepabeads (having large flat 332 
surfaces) while it is not so relevant using Eupergit (presenting not too thick 333 
fibers).[28a,47] Without the proper blocking, Sepabeads –penicillin acylase was less stable 334 
than Eupergit-penicillin acylase, while with the proper treatment, the Sepabeads 335 
biocatalyst was significantly more stable due to the higher multipoint attachment.[28a] 336 
Thus, the negative effects of the hydrophobicity of the support reverted the positive 337 
effects of a more intense multipoint covalent attachment. 338 
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 Another point to be considered is if the stabilization of a multimeric enzyme is 339 
intended via immobilization by involving all enzyme subunits.[57] A thin fiber may 340 
involve both subunits of dimeric proteins (not as easily as a flat surface), but will be 341 
unable to involve the four subunits of a tetrameric planar enzyme. Thus, in this case a 342 
support having large flat surfaces seems to be recommended. 343 
 If the immobilization of the enzyme tries to keep the enzyme properties intact, 344 
and it is performed just to have a model enzyme where aggregation or other 345 
intermolecular processes are no longer possible, a low geometrical congruence of the 346 
support surface with the enzyme seems recommended. In this case thin fibers may be a 347 
more suitable solution than large flat surfaces.[6] 348 
 Thus, the internal morphology of the support internal structure is a key point to 349 
understand the interaction between enzyme and support at a molecular level.  350 
 351 
6- Effect of the activation degree of the support on the interaction between protein 352 
and support 353 
 The number of active groups on a support surface is another key factor to 354 
control the enzyme-support multi-interaction.[6,15b] The effects are more relevant if a 355 
support having flat surfaces is used, with a lower incidence if the support is formed by 356 
thin fibers is employed.[28a,47] Only if there are several active groups under the enzyme 357 
molecule in the support, is a multi-interaction likely. This multi-interaction may be 358 
more intense when the number of reactive groups in the support increases. In a similar 359 
way, to ensure that just one interaction between enzyme and support is established, just 360 
one group should be under each enzyme molecule.[6] Considering that the surface 361 
density of reactive groups and adsorption rate are related terms (sometimes even in an 362 
exponential way), a very lowly activated support may offer an extremely low 363 
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immobilization rate.[25b] In some instances in order to get a reasonable immobilization 364 
rate a higher number of active groups in the supports is required, even although that 365 
way a just one-point attachment may be hard to ensure.[25b]  366 
 If the enzyme-support interaction is via too many points and this produce some 367 
undesired effect on the enzyme properties, it is always possible to perform an activation 368 
of the support under the maximum activation level, thus in general it is desirable that 369 
the support may offer a very high maximum number of active groups. 370 
 In some instances, for example if the support will be used for enzyme 371 
purification via affinity chromatography, a low activation of the support is preferred 372 
(Figure 13).[48,58] This is for two reasons. First, as stated before, the groups will be not 373 
physically inert and can produce the adsorption of the target protein via another 374 
mechanism not related to the affinity, or adsorb other proteins.[52,59] Second, and even 375 
more important, if there are many ligands under the enzyme molecules, and considering 376 
that the recognition pocket in the enzyme may be more or less an internal one, we are 377 
creating a “wall” where these pockets may have serious steric problems to access the 378 
ligand (and that is not solved by using large spacer arms). This way, it is possible that at 379 
a higher ligand loading, a lower affinity adsorption is achieved.[52,59]  380 
 The use of a highly activated support in a flat surface is necessary when a very 381 
intense multipoint covalent attachment is desired.[6,15b] The surfaces of a protein and a 382 
support are not complementary and only if the distance between groups fits the 383 
distances between reactive groups in the protein (inside the range of mobility of the 384 
structures), the multipoint covalent attachment may be achieved.[44a,55c,60] The 385 
possibility of this happening obviously increases if the number of groups in the support 386 
increases.[61]  387 
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 Recently it has been shown that this may be achieved also by increasing the 388 
number of reactive groups in the protein via genetic or chemical tools.[62] Nowadays, it 389 
is possible to play simultaneously with the enzyme and the support number of reactive 390 
groups.[63]  391 
 The use of supports for physical unspecific adsorption may differ if they are 392 
used for immobilization or purification. To purify enzymes (via selective desorption), 393 
the activation degree needs to be enough to adsorb many of the proteins in a crude, but 394 
not too high, to prevent problems during the desorption step. Recently, it has been 395 
proposed that a control of the activation degree may be used to purify large proteins 396 
from small ones.[51c,53] Due to the multipoint adsorption requirements, supports with the 397 
lowest degree of groups able to adsorb the target large enzyme molecule, that due to 398 
their size are able to establish long distance interactions, will only immobilize these 399 
large molecules.[51c,53] The smaller ones will be unable to become adsorbed because they 400 
cannot give a multipoint adsorption. If the target enzyme is the only large one, a full 401 
purification may be obtained just by this adsorption step (e.g., multimeric thermophilic 402 
enzymes cloned in a mesophilic host and submitted to a thermal shock).[51c,53] This 403 
strategy may be also used to selectively adsorb and even to stabilize weak multi-protein 404 
complexes, using supports able to absorb the protein complex but not the individual 405 
components.[64]  406 
 To immobilize enzymes via physical adsorption, the enzyme adsorption 407 
should be as strong as possible to prevent enzyme desorption.[54a,54b] After enzyme 408 
inactivation, the enzyme will be desorbed under drastic conditions and the support may 409 
be reused. The use of very highly activated supports has proved to be useful to get the 410 
one step immobilization-purification of large proteins if the experimental conditions are 411 
properly selected: immobilization in the presence of an adsorption competitor causes 412 
18 
 
only large proteins to become adsorbed.[16b,65] This is due to the fact that these large 413 
proteins are able to give more enzyme-support interactions per enzyme molecule than 414 
small monomeric enzymes. These large enzymes tend to be multimeric, and this 415 
adsorption involves the face of the enzyme that implies more enzyme subunits, thus the 416 
dissociation of the enzyme may be prevented (fully if the enzyme is planar) or at least 417 
decreased after immobilization.[16b,65] These strategies enable the one step 418 
purification/immobilization/stabilization and present obvious economic advantages. 419 
 420 
7- Relevance of the support active groups on the performance of a matrix for 421 
enzyme purification or immobilization. 422 
 The relevance of the nature of the active groups on the support is obvious for 423 
enzyme purification; the nature of the support must be able to permit enzyme adsorption 424 
in a selective way (e.g., affinity chromatography) or in an unspecific way (most of the 425 
used chromatographic matrices).[58d,66] Most of the active support groups are moderately 426 
stable and do not require special precautions. Other considerations have been treated in 427 
a previous point of this review; here we will only refer to the design of supports for ion 428 
exchange.  429 
 The adsorption of an enzyme molecule on ion-exchangers is based on the 430 
generation of several enzyme-support ionic interactions, exchanging the counter-ions of 431 
the enzyme and support (Figure 14).[49d,67] That means that the net charge of a protein is 432 
not enough to define the possibility of the protein to become adsorbed onto ion 433 
exchangers, but their capacity to establish an ionic net with the support is the key to 434 
permit this adsorption.[64b] This has been clearly exemplified when mixed cation-anion 435 
supports have been designed, having a “null net charge” in the surface and have been 436 
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able to adsorb many proteins, some of them are unable to become adsorbed on similar 437 
fully cationic or fully anionic supports under similar conditions (Figure 15).[68]  438 
 On the other hand, the reactive group properties are critical if the support is 439 
going to be used in enzyme covalent immobilization. The properties of the support 440 
group will determine if it may be considered a good or a bad immobilization 441 
methodology to get a very intense multipoint covalent attachment.[6] The properties of 442 
the ideal group to get an intense multipoint covalent attachment may be resumed in the 443 
following points: 444 
- The reactive group should react with groups of the enzyme frequently placed on the 445 
enzyme surface (one of the target groups is the ε-amino group of Lys). It is interesting 446 
to involve the maximum number of enzyme groups on the immobilization. 447 
- They should be able to immobilize enzymes in a broad range of conditions, to be used 448 
with a wide range of enzymes, or alter the enzyme orientation (Figure 16).[18,20] In many 449 
instances, after a first enzyme immobilization, the proximity of the support groups to 450 
the enzyme may permit to increase the enzyme reactivity with the support, and that way 451 
some attachments may be established,[19] and may stabilize the enzyme and permit the 452 
incubation under harsher conditions, conditions that can permit a more intense 453 
multipoint covalent attachment. 454 
- They should preferably react with the enzyme without any kind of activation step 455 
(avoiding complex and dangerous activation of the protein before its immobilization).[6]  456 
- They should be stable under a wide range of experimental conditions, the half live 457 
under storage conditions should be measured in months-years, under the immobilization 458 
conditions should be measured at least in weeks. Multipoint covalent attachment is a 459 
slow process that requires the correct alignment of the enzyme and support groups, 460 
depending on the support reactivity and the enzyme an optimal immobilization can take 461 
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between 3 h and one week.[61] Moreover, in order to favor the reactivity of the 462 
nucleophilic groups presented in the enzyme, alkaline pH are usually the most adequate 463 
to produce an intense multipoint covalent attachment.[61]  464 
- They should permit the enzyme-support reaction with very low steric hindrances. The 465 
multipoint covalent attachment is a quite complex process that requires the alignment of 466 
groups placed in rigid structures. This process is difficult enough even if the reaction 467 
has no steric hindrances to the reaction.[6]  468 
- They should permit some simple end point to the enzyme-support reaction, to prevent 469 
undesired enzyme-support reactions and to produce a final inert surface (see in point 9 470 
of this review the relevance of this).[6]  471 
-The changes in physical properties of the enzyme should be kept to a minimum (e.g., 472 
changing primary to secondary amino groups may be preferred to changes to amide 473 
groups).[6] 474 
-They should permit simple immobilization protocols. At industrial level, where 475 
perhaps hundreds or even thousands of kg of support may be used, the use of complex 476 
support treatments may become a serious drawback.[6]  477 
 Following literature, there are a handful of reactive groups that may be adequate, 478 
although all of them have certain drawbacks. 479 
 Glutaraldehyde chemistry is perhaps the most widely used protein covalent 480 
immobilization methodology in the literature.[69] Many of its characteristics are far from 481 
the ideal support. For example, the glutaraldehyde activated support is not very stable 482 
even at low temperature even at neutral pH value.[69b] At alkaline pH values the stability 483 
is really very short. Moreover, there are some steric hindrances to the enzyme-support 484 
reaction. However, it has some good properties: primary amino groups will be involved 485 
in the reaction and they are transformed to secondary amino bonds. Moreover, the 486 
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chemical reactivity of the support may be suppressed by reduction with sodium 487 
borohydride but it is not strictly required due to chemical changes of the glutaraldehyde 488 
molecules along time.[69b] Thus, it did not seem the best option to get an intense 489 
multipoint covalent attachment. However, the full potential of this reagent for enzyme 490 
immobilization has been recently reported, showing its large versatility in enzyme 491 
immobilization. Glutaraldehyde activated supports are normally prepared from supports 492 
bearing primary amino groups, and under standard conditions, they mainly react with 493 
primary amino groups of the protein. That way, a glutaraldehyde activated support is 494 
really a heterofunctional support:[69b] they have a chemical reactive group, but also an 495 
anion exchanger, and certain hydrophobicity (Figure 17). This support has been recently 496 
reviewed, and here we will rapidly resume some of its characteristics.[69b] The activation 497 
may involve one or two glutaraldehyde molecules per amino group on the support, 498 
being the activation with two glutaraldehyde molecules which gives the highest 499 
reactivity versus amino groups.[70] Using very high ionic strength, the first enzyme 500 
insolubilization may be via hydrophobic adsorption.[71] Using a low ionic strength, the 501 
first enzyme immobilization will be via anion exchange.[71] If a moderate ionic strength 502 
is used (except in the case of lipases), the enzyme will be immobilized via a first 503 
covalent attachment.[71] In the case of lipases, the immobilization under these conditions 504 
is produced via interfacial activation versus the hydrophobic layer of glutaraldehyde 505 
dimers. To get an immobilization via covalent attachment, detergents also need to be 506 
added.[71b] This way, the enzyme may become immobilized on the support following 507 
different mechanisms, involving different areas and producing different results in terms 508 
of activity, stability, selectivity or specificity. As all this needs to be performed at a 509 
maximum pH of 8, the enzyme-support multipoint covalent attachment may be not very 510 
intense.  511 
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 To solve this, it is possible to adsorb the enzyme molecules in a support 512 
containing primary amino groups and later treat the composite with glutaraldehyde.[72] 513 
This strategy has been recommended as the most suitable to get an intense multipoint 514 
covalent attachment using glutaraldehyde chemistry, as it involves the reaction between 515 
two amino-glutaraldehyde groups, quite reactive even at neutral pH values. However, it 516 
implies the global modification of the enzyme surface and this may be a problem in 517 
certain cases.[72] The existence of a surface under the enzyme with cationic and 518 
hydrophobic groups may also generate some problems on enzyme stability,[6] and also 519 
make the development of methodologies of enzyme reactivation via unfolding-refolding 520 
strategies complex.[73] Thus, this reagent has some potential to stabilize enzymes, but 521 
also some drawbacks. 522 
 One of the support reactive groups that has afforded the highest enzyme 523 
stabilization factors after immobilization is the glyoxyl.[25c] Glyoxyl (usually agarose) 524 
has given the highest values of stabilization via immobilization of many enzymes. 525 
Glyoxyl group is very stable, does not present steric hindrances for the reaction 526 
with the enzyme and can react with the primary amino groups of enzymes. The mild 527 
reduction with sodium borohydride converts the aldehyde groups in inert hydroxyl 528 
groups and the reversible imino bonds formed with the enzyme in very stable secondary 529 
amino bonds.[74] They have peculiar features; under standard conditions they can only 530 
fix enzyme molecules to the support via a multipoint covalent attachment.[25b] This 531 
makes that the immobilization is directed via the area where there are most Lys 532 
residues, that is the one where the highest prospects of getting a high multipoint 533 
covalent attachment exist. The main limitations of these groups is the necessity of 534 
performing a reduction as reaction end-point (some enzymes cannot withstand even 535 
very mild reductions), and the necessity for immobilizing the enzyme at alkaline pH, 536 
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around 10, to permit the simultaneous establishment of several enzyme-support linkages 537 
that will permit the enzyme fixation to the support.[25c] This necessity has been 538 
converted in an advantage. First, these supports may permit the one-step purification, 539 
immobilization and stabilization of multimeric enzymes having the terminal amino 540 
groups (with a pK between 7 and 8.5) in the same plane by performing the 541 
immobilization at neutral pH value.[25a,75] Second, they are very suitable supports to 542 
prepare heterofunctional supports (see [20]). Glyoxyl heterofunctional supports bear 543 
groups able to fix the enzyme to the support via a desired mechanism and glyoxyl 544 
groups to have a former intense multipoint covalent attachment.[76] As glyoxyl supports 545 
cannot immobilize most enzymes at pH 7, at this pH the orientation of the enzyme will 546 
determined by the other groups (ionic groups, IMAC, thiol, etc.), altering the enzyme 547 
orientation regarding the support surface. The immobilization via different orientations 548 
may alter the enzyme stability, because not all areas have the same relevance for 549 
enzyme stability. Moreover, this strategy has been revealed as a simple way to tune 550 
enzyme selectivity, specificity or resistance to inhibitors.[20] Rocha-Martin, J., Acosta, 551 
A., Berenguer, J., Guisan, J.M., Lopez-Gallego, F. Selective oxidation of glycerol to 552 
1,3-dihydroxyacetone by covalently immobilized glycerol dehydrogenases with higher 553 
stability and lower product inhibition (2014) Bioresource Technology, 170, pp. 445-554 
453. 555 
Moreover, immobilization on glyoxyl supports may be performed using neutral 556 
pH values if an imino bond stabilizer is added to the immobilization medium: tri-557 
methyl-aminoborane, cyano-borohydride or thiol groups.[77] In this case, enzyme 558 
immobilization will proceed via the most reactive group (that tends to be the terminal 559 
amino group), that may be near to other primary amino groups (or not, avoiding an 560 
intense multipoint covalent attachment).  561 
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 Epoxy activated supports groups are very popular immobilization 562 
matrices.[28c,46,78] Different epoxy supports have been commercialized by several 563 
companies and some industrial biocatalysts are prepared on them.[28c,78] They can react 564 
not only with amino groups, but also with thiol, hydroxyl and even carboxylic acids,[79] 565 
have no steric hindrances towards the reaction and present a good stability under a 566 
broad range of conditions. After immobilization, the remaining epoxy groups may be 567 
blocked by any compound having amino or thiol groups, leaving a chemically inert 568 
surface, but it is more difficult to have a fully physically inert support surface (the 569 
blocking reagents are not physically inert).[28a] However, they can immobilize enzyme 570 
molecules in a very slow fashion, because their reactivity is not very high.[80] In fact, 571 
commercially available epoxy-supports have some hydrophobicity and the companies 572 
recommend the use of high salt concentrations during enzyme immobilization. This is to 573 
force the hydrophobic adsorption of the enzymes to these supports, after this the 574 
enzyme-support reactions become intramolecular and the enzyme may become 575 
covalently attached to the support on a reasonable time. Based on this idea, a battery of 576 
different epoxy-heterofunctional supports have been developed, now the first adsorption 577 
may be via ionic exchange, thiol exchange, adsorption on immobilized borane or 578 
immobilized metal chelates, or even more specific (dyes) introduced in the support via 579 
different techniques.[20,28b,81] However, the low reactivity of the epoxy groups becomes a 580 
problem and stabilizations using epoxy activated supports are lower than that obtained 581 
using glyoxyl supports under comparable conditions (support activation degree and 582 
nature, enzyme orientation, etc.).[76b]  583 
Activation of the supports with di-vinyl-sulfone (DVS) has been recently 584 
proposed as an alternative to the epoxy supports to get an intense multipoint covalent 585 
attachment (Figure 18).[82] These supports have been used for a long time for enzyme 586 
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immobilization,[83] but only recently their features for producing intense multipoint 587 
covalent attachment of enzymes have been analyzed. The enzyme groups that are 588 
involved in the immobilization and other properties (stability, steric hindrances, end 589 
point of the reaction) are similar to epoxy supports (except reactivity versus carboxylic 590 
acids), but they are far more reactive. In fact, they immobilize proteins from pH 5 to 10, 591 
and produce very intense multipoint covalent attachments after adequate incubations.[82] 592 
The results show that they can give even more intense multipoint covalent attachment 593 
than glyoxyl supports because the longer spacer arm (see section 9 of this review) and 594 
the implication of groups different to primary amino groups.[82] Stabilization is in some 595 
instances also higher than using glyoxyl supports, although in certain cases the activity 596 
recovery is too low or the stabilization did not reach the values obtained using glyoxyl 597 
supports, even after having more enzyme-support attachments.[84] The fairly 598 
hydrophobic nature of the group has been used to explain these results. These supports 599 
have been used to modulate lipase properties by immobilizing the enzymes under 600 
different conditions, favoring the first immobilization by one or another type of amino 601 
acid[85] However, they cannot be used in heterofunctional supports due to their 602 
moderate-high reactivity in a very wide range of conditions. It would be very hard to 603 
discard the DVS covalent immobilization and ensure the implication of the secondary 604 
groups in the first enzyme immobilization. 605 
The protocols to get multipoint to covalent attachment involve some steps and 606 
long immobilization periods. Economic balance will depend on the final stabilization 607 
achieved (that should increase the operational life of the immobilized enzyme). Epoxy 608 
activated matrices are the only ones that are already produced in an activated form, 609 
glyoxyl and DVS activated supports may be produced by a support-producing company 610 
(require activation steps that not all biotechnological companies can perform) and 611 
Comentario [AB1]: Queremos decir “to 
get from multipoint to covalent” u otra 
cosa? No queda claro 
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supplied to the final user. Glutaraldehyde, due to the low stability of the active group, 612 
needs to be prepared at the moment of use. These facts may also condition the final 613 
selection by a company of the immobilization protocol. 614 
That way, the search for new support activation methods for enzyme 615 
immobilization via multipoint covalent attachment still remains as one of the more 616 
relevant topics of research in enzyme technology. 617 
 618 
8- Effect of the spacer arm length on the intensity of the interaction between 619 
protein and support  620 
 The nature and length of the spacer arm has a great relevance on the behavior of 621 
a support for enzyme purification and immobilization. The longer the spacer arm, the 622 
higher mobility will have the support reactive group and the higher area of the protein 623 
may become involved in the enzyme support multi-interaction (Figure 19).[6] Moreover, 624 
the spacer arm may not be fully inert (e.g., an arm of CH2 groups will become quite 625 
hydrophobic if it is too long), producing undesired interactions with the enzyme. 626 
 Thus, the length of the spacer arm will need to consider the exact purpose of the 627 
support. 628 
 In the purification of proteins via affinity chromatography, the ideal spacer arm 629 
should be quite long, to prevent any steric hindrance to the entry of the ligand to the 630 
enzyme recognition site.[52] The nature of the spacer arm, to avoid risks of hydrophobic 631 
interactions, should be a hydrophilic and flexible non-ionic polymer, such as dextran,[86] 632 
or even the sugar chains if the enzyme is glycosylated.[87] However, the activation of the 633 
dextran should be very low; the introduction of several ligands on the polymer may 634 
produce unspecific adsorptions of the enzyme.  Moreover, the number of groups should 635 
be related to the length of the dextran to prevent that ligands placed in different dextran 636 
27 
 
molecules may simultaneously interact with protein molecules (that is, enabling again a 637 
certain undesired multi-interaction). 638 
 The use of IMAC columns to purify poly-His-tagged proteins is different. Native 639 
proteins require the interaction with several metal ligands; His tagged enzymes may 640 
become adsorbed in just one chelate.[49h,50a,88] A long spacer arm will increase the 641 
possibilities of multi-interaction; therefore, the selectivity of the adsorption will 642 
decrease.[45] In fact, it has been shown that the promotion of a dextran over the IMAC 643 
groups favored the selectivity of the adsorption (that is, an even “negative” spacer arm 644 
seems to be preferred).[51d]  645 
 In order to get a massive physical adsorption of proteins (both for purification or 646 
immobilization), a long spacer arm seems to be preferred, to favor the multi-interaction. 647 
In fact, polyethylenimine (PEI) or dextran sulfate coated supports have been described 648 
as optimal cationic supports to strongly but reversibly immobilize proteins, even more 649 
than 90% of proteins contained in a crude may be immobilized on each of both supports 650 
at pH 7 (that means that a large percentage of proteins immobilize on both supports 651 
under identical experimental conditions).[54a,54b,89] Moreover, as this coating forms a 652 
polymeric bed, PEI coated supports permit a tridimensional chromatography, useful to 653 
purify proteins that cannot become immobilized on planar surfaces.[90]  654 
 In covalent immobilization, the spacer arm plays different roles. A long spacer 655 
arm may reduce steric hindrances for the enzyme-support reaction, but reduces the 656 
rigidity conferred via multipoint covalent attachment (Figure 19).[6] On the other hand, a 657 
long spacer arm may involve more percentage of the surface of the protein in the 658 
immobilization, increasing the number of groups involved in the multipoint covalent 659 
attachment. If the arm is hydrophobic, this may have some negative effects on enzyme 660 
thermal stability. Next, we will show some examples of these facts. 661 
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 Lowly activated dextran is an ideal spacer arm to have an immobilized enzyme 662 
with properties fairly similar to the free enzyme.[86] The enzyme is able to have freedom 663 
of movement, but may be recovered, which may be the best way to evaluate a protein in 664 
absence of any possibility of aggregation or other intermolecular artifacts. Enzymes will 665 
almost keep their properties unaltered after one-point immobilization (for example 666 
stability). Immobilization of renin or protein A using dextran activated supports has 667 
permitted to keep the activity of the enzyme and the recognition capacity almost intact, 668 
because of the decrease in the steric hindrances for the contact with the very large 669 
substrates.[86]  670 
 Glyoxyl groups have a very short spacer arm (O-CH2-CHO), permitting to 671 
transmit the rigidification achieved by the multipoint covalent attachment, and being 672 
long enough to avoid that the support surface may generate some steric hindrances to 673 
the reaction[25] . Moreover it is so short that it does not produce any physical interaction 674 
with the enzyme. DVS activated supports (O-CH2-CH2-S-CH=CH) is longer, and 675 
permits a more intense multipoint covalent attachment.[82] However, the effects on 676 
enzyme stability are not always improved accordingly, because the rigidity conferred 677 
for the bonds is not so high, and they have a certain hydrophobicity, that may have 678 
negative effects for enzyme properties.[82]  679 
 Thus, a long enough spacer arm is preferred to a group directly on the surface, 680 
but if the spacer is too long, the rigidity transmitted may be decreased. Epoxy 681 
heterofunctional supports are a clear example that shows that the promotion of any 682 
problem to the enzyme-support reaction has a negative effect on the number of enzyme 683 
support bonds achieved.[18,81b,91] The modification of the epoxides with different 684 
moieties to get the adsorption of the enzymes produced the existence of a layer of these 685 
groups over the epoxide layer, and that makes it very difficult to get an intense 686 
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multipoint covalent attachment. This occurs even if just a SH group was the one used to 687 
modify the epoxy layer, and increases when the length of the ligand group increases.[92]  688 
 689 
9- Relevance of the inertness of the support surface of the support for enzyme 690 
immobilization or purification 691 
 In this point, it is convenient to consider that the inertness of the support will 692 
affect both the matrix itself and the groups that the researcher introduces to perform the 693 
enzyme incorporation to the support. At first glance, the final inertness of the support 694 
core is in most cases advantageous, both in immobilization and purification.[6] It should 695 
be considered that polysaccharides matrices like agarose and cellulose beads are among 696 
the most inert ones, very similar to water (water may be considered the material 697 
showing maximum inertness). In general, the researcher should look for matrices as 698 
similar to these as possible.  699 
The final inertness of the active groups placed in the support surface is a more 700 
complex target. In purification or in immobilization of enzymes via physical adsorption, 701 
the groups placed on the support will keep their capacity for physical interactions over 702 
time, and that is inevitable.[6] However, if a covalent immobilization is performed, it is 703 
possible and recommendable to have a final surface as inert as possible, both chemical 704 
and physically.[6] 705 
 In purification, an inert surface is critical to avoid enzyme adsorption via another 706 
mechanism different to that designed by the researcher. If an uncontrolled mixed 707 
adsorption is produced, desorption of the enzyme may become quite difficult, and the 708 
results obtained may be difficult to understand. Moreover, this secondary interaction of 709 
the enzyme and the support may be responsible for enzyme inactivation and other 710 
undesired effects. Obviously, the active group in the support surface will remain being 711 
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able to interact with the protein continuously. This may cause a not very frequently 712 
studied phenomenon:  if the adsorbed enzyme is desorbed immediately after adsorption, 713 
this may be achieved under much milder conditions that when the adsorbed enzyme is 714 
left to interact with the support for several hours).[51d] This is caused by the increase in 715 
the enzyme-support bonds number; to reach the maximum level of enzyme-support 716 
interactions a certain time is required after the enzyme is already incorporated to the 717 
support, as explained for the multipoint covalent attachment, but now becoming an 718 
undesired effect. 719 
 For enzyme immobilization via physical adsorption, a controlled mixed 720 
adsorption may be interesting to prevent enzyme desorption during operation. However, 721 
it is more suitable to get this if the researcher introduces both kinds of groups on the 722 
support, because that way the relevance of each phenomenon may be controlled. An 723 
example of this may be the interfacial activation of lipases versus hydrophobic supports 724 
(Figure 20).[93] This lipase immobilization method is very useful and has a handful of 725 
advantages (e.g., involve the open form of the lipase),[94] but the enzyme may be 726 
released to the medium in the presence of organic solvents.[95] If the support also has 727 
some ionic groups, able to form some ionic bridges after enzyme interfacial activation, 728 
this may improve the usefulness of these preparations.[96] The idea has been already 729 
used, even transformed to produce covalently forms of lipases interfacially activated 730 
versus hydrophobic supports.[97]  731 
 If the enzyme is covalently attached to the support, it is possible to design 732 
strategies to have a surface as inert as possible. For example, reduction of glyoxyl-733 
agarose supports produces a support having just inert hydroxyl groups.[74] The blocking 734 
of epoxy or DVS activated supports may also get surfaces moderately inert.[28a,82] Using 735 
glutaraldehyde, an inert surface is not possible; the cationic group will remain there, 736 
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together with the hydrophobicity of the glutaraldehyde groups.[69b,71] The possibility of 737 
physical enzyme-support interactions may have different effects on enzyme features, 738 
from stability to activity or selectivity, usually the effects are difficult to predict and in 739 
most cases negatives. However, in certain cases, the change of the support surface 740 
physical properties during blocking has been used to modulate the enzyme 741 
properties.[98] Results using this technique may be positive in certain reactions and 742 
conditions and very negative in other ones. 743 
 If the enzyme is going to be submitted to strategies of unfolding/refolding to 744 
recover their activity after inactivation, the inertness of the support has a markedly 745 
special relevance This strategy has been employed with some success with different 746 
immobilized enzymes, even it has been reported than a multipoint covalent attachment 747 
improves the rate and yield of recovered enzyme activity after unfolding/refolding.[99] 748 
Most results have been reported using enzymes immobilized on inert glyoxyl-enzyme 749 
biocatalysts, thanks to their inertness. However, if the support is able to interact with 750 
groups of the enzyme, partially unfolded structures may become stabilized and the 751 
correct enzyme refolding may become not possible.[73,100]  752 
 In other cases, some positive effects of immobilization derive directly for the 753 
physical properties of the support surface. This is the case of the partition of some 754 
deleterious compounds away from the enzyme molecules by immobilization on 755 
polymeric beds. Thus, enzymes stability has been improved versus organic solvents or 756 
oxygen by using supports coated with ionic polymers,[101] while the coating with 757 
hydrophobic polymers has improved the stability versus hydrogen peroxide.[102] 758 
Immobilization of lipase B from Candida antarctica on hydrophobic supports permitted 759 




10- Conclusions 762 
 The design of supports to be used in immobilization or purification requires a 763 
deep knowledge of the phenomena that can occur between a support surface and a 764 
biomacromolecule. Many macroscopic and molecular level features need to be 765 
considered in the design of the support, with different relevance depending on the final 766 
use of the support and of the biocatalyst and most of them are interacting some way 767 
each other and in many instances a compromise solution need to be taken to have an 768 
overall good matrix. This review has tried to point some of the most relevant features of 769 
a support, and shown the many possibilities that the research has and the many 770 
decisions that may be taken before selecting a determined support.  Immobilization and 771 
purification of enzymes using activated supports have very different objectives, but in 772 
fact are quite related topics, the researcher needs to determine the cause for the first 773 
enzyme insolubilization (one strong interaction or weak multipoint interactions) and 774 
avoid or at least, control any other likely support-enzyme interactions. The potential of a 775 
proper support used under proper conditions may be impressive and with many 776 
applications. A proper design of a support may permit to shift equilibrium of very weak 777 
protein complexes permitting their accumulation on the support, or improve the stability 778 
of an enzyme stability thousands folds, or its activity or their selectivity. However, to 779 
fully reach these goals, it is necessary to improve the knowledge and control of the 780 
interactions between support and enzyme, and even to design new reactive groups with 781 
even better properties than the currently available ones. These apparently old fashioned 782 
techniques remain as necessary as ever in the era of the biotechnology revolution and 783 
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Figure Legends 1162 
 1163 
Figure Legends 1164 
 1165 
 1166 
Figure 1.  Immobilization and purification of enzymes by control of the support and/or 1167 
immobilization conditions. 1168 
 1169 
Figure 2. Supports for immobilization or for enzyme purification. 1170 
 1171 
Figure 3. Possibility of enzyme-support uncontrolled interactions.  1172 
 1173 
Figure 4. Effect of large support particles on the adsorption rate of the enzyme-support. 1174 
 1175 
Figure 5. Diffusional limitations by effect of a large support particle. Effect on enzyme 1176 
activity. 1177 
 1178 
Figure 6. pH gradients promotion in the production of an ionized product (e.g., 1179 
production of a carboxylic acid by hydrolysis of an ester) favored by the particle size of 1180 
the support. 1181 
 1182 
Figure 7. Immobilization support coating an ionic polymer as a solid ‘‘buffer’. 1183 
Protective effect on the enzyme. 1184 
 1185 
Figure 8. Effect of pore size on the loading capacity of the support for immobilization 1186 
and purification of enzymes. 1187 
 1188 
Figure 9. Controlling the diffusional limitations of substrates by using supports bearing 1189 
large pore diameter. 1190 
 1191 
Figure 10. Different types of standard supports for protein purification. 1192 
 1193 
Figure 11. Effect of internal geometry of the support on the possibilities of producing 1194 
one-point interactions or multipoint interactions: large surfaces versus thin fibers. 1195 
 1196 
Figure 12. Protein immobilization by physical adsorption on supports activated with 1197 
polymers or standard groups: volume versus planar adsorption.  1198 
 1199 
Figure 13. Effect of support activation degree on the effectiveness in affinity 1200 
chromatography.  1201 
 1202 
Figure 14. Immobilization and purification of enzymes on ion exchanger supports: a 1203 
multipoint interaction is required. 1204 
 1205 
Figure 15. Immobilization and purification of enzymes on mixed cation-anion supports. 1206 
 1207 





Figure 17. Glutaraldehyde supports as multifunctional supports for enzyme 1211 
immobilization. 1212 
 1213 
Figure 18. Di-vinyl-sulfone (DVS) activated supports for enzyme immobilization via 1214 
multipoint covalent attachment 1215 
 1216 
Figure 19. Relevance of the spacer arm in enzyme stabilization via multipoint covalent 1217 
attachment. 1218 
 1219 
Figure 20. Immobilization of lipases via interfacial activation on hydrophobic supports. 1220 
 1221 
Figure 21. Stabilization of lipases versus hydrogen peroxide by generation of a partition 1222 
effect using a hydrophobic support. 1223 
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